ストックスクリーナーアプリを入手
0.9299
0.53%
0.0049
アフターアワーズ：
.93
0.0001
+0.01%
Clearside Biomedical Inc (CLSD) 最新ニュース
Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Significant Decline in Short Interest - MarketBeat
Geode Capital Management LLC Buys 59,089 Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives $5.33 Average Price Target from Analysts - MarketBeat
Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Average Rating of “Buy” by Analysts - Defense World
Clearside Biomedical (NASDAQ:CLSD) Stock Price Crosses Below 50-Day Moving Average – Here’s Why - Defense World
Clearside Biomedical (NASDAQ:CLSD) Shares Pass Below 50 Day Moving AverageWhat's Next? - MarketBeat
Further weakness as Clearside Biomedical (NASDAQ:CLSD) drops 14% this week, taking five-year losses to 72% - Simply Wall St
Clearside Biomedical stock hits 52-week low at $0.92 By Investing.com - Investing.com South Africa
Clearside Biomedical stock hits 52-week low at $0.92 - Investing.com
Clearside announces publication of insights on drug development, regulation - Yahoo Finance
Analyst Sees 500% Upside for This Pharmaceutical Penny Stock - GuruFocus.com
Clearside Biomedical Announces Publication of Critical - GlobeNewswire
Clearside Biomedical Unveils Groundbreaking Insights on Retinal Drug Development in Eye Journal - StockTitan
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Brokerages Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Price Target at $5.33 - MarketBeat
Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now - MSN
Clearside Biomedical's SWOT analysis: innovative eye treatment stock faces pivotal trial - Investing.com
Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Down 11.8% in November - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Upgraded to Hold at StockNews.com - MarketBeat
Clearside Biomedical's SWOT analysis: stock poised for potential breakthrough in wet AMD treatment - Investing.com Nigeria
Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Down 13.6% in November - Defense World
Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Large Decrease in Short Interest - MarketBeat
Clearside Biomedical (FRA:CLM) Momentum Rank : 5 (As of Nov. 30, 2024) - GuruFocus.com
Clearside showcases eye therapy delivery tech By Investing.com - Investing.com South Africa
Clearside showcases eye therapy delivery tech - Investing.com
Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States - The Manila Times
Clearside Biomedical Extends Global Footprint with Numerous - GlobeNewswire
Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Clearside Biomedical (FRA:CLM) Financial Strength : 4 (As of Sep. 2024) - GuruFocus.com
Crude Oil Brent (SCU24) Quote - The Globe and Mail
Clearside Biomedical’s (CLSD) Buy Rating Reaffirmed at HC Wainwright - Defense World
What is HC Wainwright’s Forecast for CLSD FY2024 Earnings? - Defense World
What is HC Wainwright's Forecast for CLSD FY2024 Earnings? - MarketBeat
Clearside Biomedical's (CLSD) Buy Rating Reaffirmed at Chardan Capital - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Stock Rating Upgraded by StockNews.com - MarketBeat
All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy - MSN
Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Needham & Company LLC Reaffirms Buy Rating for Clearside Biomedical (NASDAQ:CLSD) - Defense World
Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at HC Wainwright - MarketBeat
Clearside Biomedical Announces Slight Revenue Increase in Third Quarter, Advances Wet AMD Treatment in Clinical Trial - Vision Monday
Earnings call: Clearside Biomedical reports progress in AMD treatment - Investing.com
0.65%
4.62%
大文字化:
|
ボリューム (24 時間):